Silence Therapeutics Ownership | Who Owns Silence Therapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

Silence Therapeutics Ownership Summary

Silence Therapeutics is owned by 60.14% institutional investors, 16.94% insiders, and 22.93% retail investors. Tcg crossover management is the largest institutional shareholder, holding 7.50% of SLN shares. Eventide Healthcare & Life Sciences I is the top mutual fund, with 1.36% of its assets in Silence Therapeutics shares.

SLN Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Silence Therapeutics	60.14%	16.94%	22.93%
Sector	Healthcare Stocks	88.01%	8.90%	3.09%
Industry	Biotech Stocks	109.70%	8.77%	-18.47%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Tcg crossover management	3.30M	7.50%	$62.61M
Artal group	2.78M	6.32%	$52.81M
Lombard odier asset management (usa)	2.41M	5.47%	$36.76M
Redmile group	2.01M	4.58%	$38.27M
Logos global management lp	1.48M	3.36%	$28.05M
Deep track capital, lp	1.36M	3.09%	$25.84M
Frazier life sciences management	1.15M	2.61%	$21.82M
Vivo capital	1.11M	2.51%	$21.00M
Nextech invest	952.40K	2.17%	$18.10M
Polar capital	940.16K	2.14%	$17.86M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Aquilo capital management	500.21K	9.16%	$9.50M
Tcg crossover management	3.30M	6.53%	$62.61M
M28 capital management lp	185.10K	4.56%	$3.52M
Nextech invest	952.40K	3.04%	$18.10M
Lombard odier asset management (usa)	2.41M	2.72%	$36.76M
Redmile group	2.01M	2.31%	$38.27M
Logos global management lp	1.48M	2.26%	$28.05M
5am venture management	476.20K	2.02%	$9.05M
Vivo capital	1.11M	1.94%	$21.00M
Artal group	2.78M	1.35%	$52.81M

Top Buyers

Holder	Shares	% Assets	Change
Ikarian capital	506.67K	0.57%	506.67K
Polar capital	940.16K	0.11%	440.16K
Millennium management	782.94K	0.01%	373.52K
Sg americas securities	343.20K	0.04%	336.20K
Janus henderson group	818.98K	0.01%	193.11K

Top Sellers

Holder	Shares	% Assets	Change
Lombard odier asset management (europe)	-	-	-2.24M
First turn management	-	-	-537.34K
Lynx1 capital management lp	-	-	-526.64K
Deep track capital, lp	1.36M	0.77%	-284.14K
Hudson bay capital management lp	-	-	-208.06K

New Positions

Holder	Shares	% Assets	Change	Value
Ikarian capital	506.67K	0.57%	506.67K	$3.29M
Fny investment advisers	17.52K	0.06%	17.52K	$120.00K
Y-intercept (hong kong)	17.16K	0.02%	17.16K	$325.94K
China universal asset management	9.96K	0.01%	9.96K	$68.55K
Vestcor	8.80K	0.01%	8.80K	$167.00K

Sold Out

Holder	Change
Lazard asset management	-60.00
Values first advisors	-3.09K
Qube research	-3.94K
Advisors preferred	-5.32K
Quarry lp	-6.00K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	70	-	28,105,051	3.61%	60	1.79%	37	12.12%	14	-26.32%
Jun 30, 2024	69	9.52%	27,125,546	-1.84%	61	1.11%	33	-31.25%	18	63.64%
Mar 31, 2024	63	85.29%	27,634,707	34.54%	74	2.46%	48	182.35%	11	83.33%
Dec 31, 2023	34	21.43%	20,540,070	4.15%	55	1.85%	17	112.50%	6	-14.29%
Sep 30, 2023	28	-3.45%	19,721,335	2.56%	54	1.91%	8	-42.86%	7	40.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Eventide Healthcare & Life Sciences I	640.00K	1.36%	640.00K
Polar Capital Biotech S Inc	467.15K	0.99%	-532.85K
iShares Biotechnology ETF	188.91K	0.40%	-1.36K
BIT Biotech Opportunities S	107.30K	0.23%	6.06K
MEDICAL BioHealth EUR Acc	107.00K	0.23%	-
T. Rowe Price Health Sciences	95.65K	0.20%	95.65K
Tema Obesity & Cardiometabolic ETF	76.77K	0.16%	-
Galileo - Biotech Innovation Fund S USD	58.65K	0.12%	-
Fidelity Nasdaq Composite Index	29.42K	0.06%	-
RIM Global Bioscience EUR	24.80K	0.05%	-

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	-

SLN Ownership FAQ

Who Owns Silence Therapeutics?

Silence Therapeutics shareholders are primarily institutional investors at 60.14%, followed by 16.94% insiders and 22.92% retail investors. The average institutional ownership in Silence Therapeutics's industry, Biotech Stocks , is 109.70%, which Silence Therapeutics falls below.

Who owns the most shares of Silence Therapeutics?

Silence Therapeutics’s largest shareholders are Tcg crossover management (3.3M shares, 7.50%), Artal group (2.78M shares, 6.32%), and Lombard odier asset management (usa) (2.41M shares, 5.47%). Together, they hold 19.29% of Silence Therapeutics’s total shares outstanding.

Does Blackrock own Silence Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Silence Therapeutics.

Who is Silence Therapeutics’s biggest shareholder by percentage of total assets invested?

Aquilo capital management is Silence Therapeutics’s biggest shareholder by percentage of total assets invested, with 9.16% of its assets in 500.21K Silence Therapeutics shares, valued at 9.5M$.

Who is the top mutual fund holder of Silence Therapeutics shares?

Eventide Healthcare & Life Sciences I is the top mutual fund holder of Silence Therapeutics shares, with 1.36% of its total shares outstanding invested in 640K Silence Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools